Gene Expression in Lower Extremity Acute Traumatic Compartment Syndrome

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
University of Utah
Study ID
NCT05521958
Status
Enrolling By Invitation

Conditions

  • Tibial Plateau Fracture
  • Tibial Shaft Fracture

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Acute injury without compartment syndrome — PROCEDURE
    Acute tibial shaft or tibial plateau fractures who do not have clinical compartment syndrome. Muscle punch biopsy of the anterior compartment will be taken.
  • Acute injury with compartment syndrome — PROCEDURE
    Acute tibial shaft or tibial plateau fractures who have clinical compartment syndrome. Muscle punch biopsy of the anterior compartment will be taken.
  • Exertional compartment syndrome — PROCEDURE
    For patients with exertional compartment syndrome, a muscle biopsy will be obtained from affected extremity.

Study Details

The purpose of this study is to evaluate both genotypic differences and differences in local gene expression in individuals who develop acute traumatic compartment syndrome relative to control patients with at-risk lower extremity fractures who do not develop compartment syndrome.

Key Dates

Start date
Jun 10, 2022
Status verified
Apr 2026
Primary completion
Jun 30, 2028
Completion
Jun 30, 2028

Study Design

Enrollment
80 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Other: Acute tibial shaft or tibial plateau fractures without compartment syndrome
    Patients with acute lower leg fractures who do not have clinical compartment syndrome.
  • Other: Acute tibial shaft or tibial plateau fractures with compartment syndrome.
    Patients with acute lower leg fractures with acute compartment syndrome.
  • Other: Exertional compartment syndrome
    Patients with a diagnosis of exertional compartment syndrome who are planning to undergo surgical procedure to release the compartment fascia will be recruited to participate prior to surgical intervention.

Primary Outcome Measure

Myostatin (% increase) [ Time Frame: Immediately after the muscle tissue harvest procedure. ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Utah Orthopaedic CenterSalt Lake CityUtah84112-

Find similar trials in Salt Lake City, UT

Related Studies